Hidenori Shiraha

Hidenori Shiraha

Auto-generated profile, based on publicly available information

Hidenori Shiraha

Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine and Dentistry, 2-5-1 Shikata-cho, Okayama 700-8558, Japan

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2009 in BMC Cancer
Verified
Journal Article
Open access
PDF file
NMNoriyuki Matsuo
Noriyuki Matsuo
HSHidenori Shiraha
Hidenori Shiraha
TFTatsuya Fujikawa
Tatsuya Fujikawa
NTNobuyuki Takaoka
Nobuyuki Takaoka
NUNaoki Ueda
Naoki Ueda
KYKazuhide Yamamoto
Kazuhide Yamamoto
Background: Twist, a transcription factor of the basic helix-loop-helix class, is reported to regulate cancer metastasis. It is known to induce epithelial-mesenchymal transition (EMT). In this study, we evaluated the expression of twist and its effect on cell migration in hepatocellular carcinoma (HCC). Methods: We examined twist expression using immunohistochemistry in 20 tissue samples of hepatocellular carcinoma, and assessed twist expression in HCC cell lines by RT-PCR and Western blot analysis. Ectopic twist expression was created by introducing a twist construct in the twist-negative HCC cell lines. Endogenous twist expression was blocked by twist siRNA in the twist-positive HCC cell lines. We studied EMT related markers, E-cadherin, Vimentin, and N-cadherin by Western blot analysis. Cell proliferation was measured by MTT assay, and cell migration was measured by in vitro wound healing assay. We used immunofluorescent vinculin staining to visualize focal adhesion. Results: We detected strong and intermediate twist expression in 7 of 20 tumor samples, and no significant twist expression was found in the tumor-free resection margins. In addition, we detected twist expression in HLE, HLF, and SK-Hep1 cells, but not in PLC/RPF/5, HepG2, and Huh7 cells. Ectopic twist-expressing cells demonstrated enhanced cell motility, but twist expression did not affect cell proliferation. Twist expression induced epithelial-mesenchymal transition together with related morphologic changes. Focal adhesion contact was reduced significantly in ectopic twist-expressing cells. Twist-siRNA-treated HLE, HLF, and SK-Hep1 cells demonstrated a reduction in cell migration by 50, 40 and 18%, respectively. Conclusion: Twist induces migratory effect on hepatocellular carcinoma by causing epithelial-mesenchymal transition.

1 March 2007 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TFTatsuya Fujikawa
Tatsuya Fujikawa
HSHidenori Shiraha
Hidenori Shiraha
NUNaoki Ueda
Naoki Ueda
NTNobuyuki Takaoka
Nobuyuki Takaoka
YNYutaka Nakanishi
Yutaka Nakanishi
YSYasushi Shiratori
Yasushi Shiratori
Des-γ-carboxyl prothrombin (DCP) is a well recognized tumor marker for hepatocellular carcinoma. Previously, we have demonstrated that DCP stimulates cell proliferation in hepatocellular carcinoma cell lines through Met-Janus kinase 1 signal transducer and activator of transcription 3 signaling pathway. In the present study, we demonstrated that DCP induces both cell proliferation and migration in human umbilical vein endothelial cells. DCP was found to bind with the kinase insert domain receptor (KDR), alternatively referred to as vascular endothelial growth factor receptor-2. Furthermore, DCP induced autophosphorylation of KDR and its downstream effector phospholipase C-γ and mitogen-activated protein kinase (MAPK). To support these results, we showed that DCP-induced cell proliferation and cell migration were inhibited by KDR short interfering RNA, KDR kinase inhibitor, or MAPK inhibitor. In conclusion, these results indicate that DCP is a novel type of vascular endothelial growth factor that possesses potent mitogenic and migrative activities.

20 January 2005 in BMC Cancer
Verified
Journal Article
Open access
PDF file
THTadashi Hanafusa
Tadashi Hanafusa
TSToshiyuki Shinji
Toshiyuki Shinji
HSHidenori Shiraha
Hidenori Shiraha
Kazuhiro NousoKazuhiro Nouso
Kazuhiro Nouso
YIYoshiaki Iwasaki
Yoshiaki Iwasaki
NKNorio Koide
Norio Koide
Background: Insulin-like growth factor binding protein (IGFBP)-3 functions as a carrier of insulin-like growth factors (IGFs) in circulation and a mediator of the growth suppression signal in cells. There are two reported p53 regulatory regions in the IGFBP3 gene; one upstream of the promoter and one intronic. We previously reported a hot spot of promoter hypermethylation of IGFBP-3 in human hepatocellular carcinomas and derivative cell lines. As the hot spot locates at the putative upstream p53 consensus sequences, these p53 consensus sequences are really functional is a question to be answered. Methods: In this study, we examined the p53 consensus sequences upstream of the IGFBP-3 promoter for the p53 induced expression of IGFBP-3. Deletion, mutagenesis, and methylation constructs of IGFBP-3 promoter were assessed in the human hepatoblastoma cell line HepG2 for promoter activity. Results: Deletions and mutations of these sequences completely abolished the expression of IGFBP-3 in the presence of p53 overexpression. In vitro methylation of these p53 consensus sequences also suppressed IGFBP-3 expression. In contrast, the expression of IGFBP-3 was not affected in the absence of p53 overexpression. Further, we observed by electrophoresis mobility shift assay that p53 binding to the promoter region was diminished when methylated. Conclusion: From these observations, we conclude that four out of eleven p53 consensus sequences upstream of the IGFBP-3 promoter are essential for the p53 induced expression of IGFBP-3, and hypermethylation of these sequences selectively suppresses p53 induced IGFBP-3 expression in HepG2 cells.

1 June 2004
Verified
Journal Article
Closed access
TSToshiyuki Shinji
Toshiyuki Shinji
YKYi Yi Kyaw
Yi Yi Kyaw
KGKatsunori Gokan
Katsunori Gokan
YTYasuhito Tanaka
Yasuhito Tanaka
KOKoji Ochi
Koji Ochi
NKNorio Koide
Norio Koide

3 May 2012 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Open access
PDF file
MMMinoru Matsubara
Minoru Matsubara
HSHidenori Shiraha
Hidenori Shiraha
JKJyunro Kataoka
Jyunro Kataoka
MIMasaya Iwamuro
Masaya Iwamuro
SHShigeru Horiguchi
Shigeru Horiguchi
KYKazuhide Yamamoto
Kazuhide Yamamoto
Background and Aim:  Hepatocellular carcinoma (HCC) is a hypervascular tumor, and angiogenesis plays an important role in its development. Previously, we demonstrated that des‐γ‐carboxyl prothrombin (DCP) promotes both cell proliferation and migration of human umbilical vein endothelial cells (HUVECs) by inducing the autophosphorylation of kinase insert domain receptor (KDR). In the present study, DCP‐associated tumor angiogenesis was assessed by comparing hypovascular and common hypervascular HCC.Methods:  The solitary HCCs of 827 patients were classified into two groups according to the tumor density at the arterial phase of a dynamic computed tomography scan; the initial clinical data of patients with the hyper‐ and hypovascular types were compared. The HCC tissues from 95 tumors were analyzed by immunohistochemical staining for DCP and phosphorylated KDR, and intratumoral microvessel density (MVD) was analyzed to evaluate microvessel angiogenesis.Results:  The serum DCP levels (320 ± 3532 mAU/mL) and tumor size (18.4 ± 9.0 mm) of patients with hypervascular HCC were significantly greater than those with hypovascular HCC (38.7 ± 80 mAU/mL and 14.6 ± 5.2 mm, P < 0.001). Immunohistochemical analysis revealed that the expressions of DCP and phospho‐KDR were significantly greater in hypervascular HCC (71.4% and 31.0%, respectively) than in hypovascular HCC (7.6% and 5.7%, respectively). Intratumoral MVD was significantly correlated with DCP (r = 0.48, P < 0.0001).Conclusions:  des‐γ‐carboxyl prothrombin production is associated with tumor angiogenesis in HCC.

16 February 2011 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
HSHidenori Shiraha
Hidenori Shiraha
SNShin‐Ichi Nishina
Shin‐Ichi Nishina
KYKazuhide Yamamoto
Kazuhide Yamamoto